On January 5, 2024, the Food and Drug Administration (FDA) issued a letter authorizing the state of Florida’s Section 804 Importation Programs (SIP) proposal (Authorization Letter).

The Office of the National Coordinator for Health Information Technology (ONC) issued a final rule on Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (Final Rule), which is scheduled to be published in the Federal Register on Jan. 9, 2024.

AMCP Regulatory NewsBREAK: CMS Issues Letter to Plans and Pharmacy Benefit Managers

• On Nov. 6, 2023, the Centers for Medicare and Medicaid Services (CMS) issued a memorandum titled Application of Pharmacy Price Concessions to the Negotiated Price at the Point of Sale Beginning Jan. 1, 2024 (Memo).

Due to the COVID-19 PHE, flexibilities were implemented to prevent lapses in patient care by allowing the prescribing of schedule II-V controlled medications via audio-video telemedicine encounters – including schedule III-V narcotic controlled medications approved by the Food and Drug Administration (FDA) for maintenance and withdrawal management of opioid use disorder – even when the prescribing practitioner had not conducted an in-person medical evaluation of the patient.

Due to the COVID-19 PHE, flexibilities were implemented to prevent lapses in patient care by allowing the prescribing of schedule II-V controlled medications via audio-video telemedicine encounters – including schedule III-V narcotic controlled medications approved by the Food and Drug Administration (FDA) for maintenance and withdrawal management of opioid use disorder – even when the prescribing practitioner had not conducted an in-person medical evaluation of the patient.